Infectious Disease "challenge" studies are ones in which healthy participants are intentionally infected with pathogens in order to investigate the cause, prevention, and treatment of infectious diseases- but are they ethical? These studies, while useful, pose ethical concerns, and numerous criteria must be met for an infectious challenge to be ethically permissible.
Read this whitepaper to learn more about ethical concerns as well as the biosafety considerations when conducting infectious disease challenge studies.
Other content in this Stream
Jonca Bull, MD: We Should Not Be Surprised — COVID-19 Disparities Lay Bare What’s Been There All Along
In this episode, former Assistant FDA Commissioner Jonca Bull, MD, discusses racial disparities in healthcare, how COVID-19 has made them impossible to ignore, and how this highlights the need for div
Dr. Edith Mitchell, MD: COVID-19 Doesn't Play Fair — What We Need to Understand About Racial Disparities
Dr. David Fajgenbaum, MD, Castleman’s Disease Survivor, Facing COVID-19 with Research, Action, and Hope
COVID-19 Insights from Former FDA Commissioner, Scott Gottlieb, MD
The coronavirus has spread beyond the point of containment, and there’s a looming shortage of personal protective equipment. Hear insights from former FDA Commissioner, Scott Gottlieb, MD.
COVID-19 Preparedness for Health Care Institutions with Dr. Paul Biddinger of Massachusetts General Hospital
Save the Data. Protect the Patients. Prepare for What Comes Next: Remote Clinical Research Coordinators
1:01:03PART 12: Public Awareness of Clinical Research and the Path To Diversity in Clinical Trials
59:47PART 11: The Impact of COVID-19 on Oncology Research: Immediate and Long-term Effects
1:00:51PART 10: Unique Challenges and Opportunities for Emerging Biopharma Companies with Focused Pipelines
